Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, another busy day is on the way. And while this is shaping up to be a rather cold one, in fact, the sun is shining strongly over the hectic Pharmalot corporate campus, where the short people are enduring their usual ritual of hustling off to their houses of learning. As for us, we are, of course, indulging with a cup of needed stimulation as we sort through our to-do list and decide what to leave in and what to leave out. Perhaps you can relate. In any event, here are some items of interest to help along your own ride. Have a smashing day and drop us a line if something interesting occurs... CVS And Cardinal Form A Generic Drug Supply Venture (Bloomberg News) Glaxo To Invest $330 Million In Manufacturing In The UK (Reuters) Acid Reflux Drugs Linked To Vitamin B12 Deficiency (The New York Times) Patient Groups Say Obamacare Discourages HIV Patients (The Wall Street Journal) AbbVie Releases Promising Data On Its Hepatitis C Drug (Pharma Times) Teva Vice Chairman Leaves For Personal Reasons (Globes) A Withdrawn AML Drug Gets A Second Look (MedPage Today) Teva To Miss 2014...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs